Escaping Big Pharma's Pricing With Patent-Free Drugs


For profit-driven pharmaceutical companies, there is little incentive to innovate with treatments for diseases most often found in impoverished countries, because of an inability to pay exorbitant prices. The Drugs for Neglected Diseases Initiative works to create low-cost, patent-free treatments for diseases ignored by profit-driven decisions, and has created new treatments for seven diseases.

Related Stories